This confederation of projects is concerned with the study of transformed cells. The goals of this highly integrated Program Project are to create peptidic forms of several classes of molecules that may aid in the development of an immune response to transformed cells or that might disable the transformed phenotype more effectively. The general principles that are addressed in this """"""""revised"""""""" program relate to the problem of tumor immunity and how to use small peptidic forms of macromolecular species to modify the transformed phenotype and growth of tumors. A group of scientists interested in the reduction of macromolecules into secondary structural forms with biological activity have been working together for several years. Now, under the auspices of a Program Project format, they will develop this well defined research focus involving multiple disciplines and varied aspects of immunology and cell biology into an inter-related and synergistic Program. The basic structural design of peptide forms and their improvement is guided by Greene, Murali, and Kieber-Emmons. All of these investigators have worked closely together for the last several years and are specialists in structural applications. In addition, an NMR specialist, Joshua Wand, will aid in the resolution of the atomic basis of the peptides' effects through the Structural Core which includes biophysical analysis of binding features as well as structural resolution units. The great immunologic strength in the areas of immunoglobulins and their application to tumors is aided by the laboratories of Ferrone, Greene, and Herlyn, experts in murine and human tumor immunology. The scientists involved in this Program all have worked in the general area of immunoglobulin function, and through these early efforts have come to focus on structural elements that guide immunity and receptor function. It is this process which has led to a focus on peptides which mimic secondary structural features. The use of peptidic mimics and linkers ultimately may have application to the treatment of human breast, lymphoid, and epithelial tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA089480-01A2
Application #
6513635
Study Section
Subcommittee G - Education (NCI)
Program Officer
Hecht, Toby T
Project Start
2002-05-13
Project End
2006-04-30
Budget Start
2002-05-13
Budget End
2003-04-30
Support Year
1
Fiscal Year
2002
Total Cost
$1,286,288
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Murali, Ramachandran; Greene, Mark I (2012) Structure based antibody-like peptidomimetics. Pharmaceuticals (Basel) 5:209-35
Ponde, Datta E; Su, ZiFen; Berezov, Alan et al. (2011) Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agent. Bioorg Med Chem Lett 21:2550-3
Monzavi-Karbassi, Behjatolah; Hine, R Jean; Stanley, Joseph S et al. (2010) Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells. Int J Oncol 37:615-22
Zhang, Tianqian; Herlyn, Dorothee (2009) Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer. Cancer Immunol Immunother 58:475-92
Cai, Z; Zhang, G; Zhou, Z et al. (2008) Differential binding patterns of monoclonal antibody 2C4 to the ErbB3-p185her2/neu and the EGFR-p185her2/neu complexes. Oncogene 27:3870-4
Wondimu, Assefa; Zhang, Tianqian; Kieber-Emmons, Thomas et al. (2008) Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice. Cancer Immunol Immunother 57:1079-89
Monzavi-Karbassi, Behjatolah; Stanley, J Steven; Hennings, Leah et al. (2007) Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer 120:1179-91
Ko, Eric; Luo, Wei; Peng, Liaomin et al. (2007) Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity. Cancer Res 67:7875-84
Zhang, Hongtao; Berezov, Alan; Wang, Qiang et al. (2007) ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 117:2051-8
Whitehead, Tracy L; Holley, Andy W; Korourian, Soheila et al. (2007) (1)H nuclear magnetic resonance metabolomic analysis of mammary tumors from lean and obese Zucker rats exposed to 7,12-dimethylbenz[a]anthracene. Int J Mol Med 20:573-80

Showing the most recent 10 out of 40 publications